Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Contrast Induced Nephropathy by Erythropoietin in Patients With Diabetes Mellitus and eGFR<60 ml/Min/1.73m2 Undergoing Percutaneous Coronary Intervention

NCT01364402 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

NCT NCT01364402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01364402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Contrast Induced Nephropathy by Erythropoietin in Patients With Diabetes Mellitus and eGFR<60 ml/Min/1.73m2 Undergoing Percutaneous Coronary Intervention
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2011
Completion date
December 31, 2013
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney insufficiency, diabetes